Boost Your Productivity!Translate documents (Ms-Word, Ms-Excel, ...) faster and better thanks to artificial intelligence!
https://pro.wordscope.com
https://blog. wordscope .com
ART
Antiretroviral therapy
Antiretroviral treatment
Combination therapy
Combined antiretroviral therapy
Dietary therapy
FEF50%
Highly active antiretroviral therapy
MMFR
Maximal mid-expiratory flow rate
Nutrition therapy
Nutritional therapy
Offer neuromusculoskeletal therapies
Offer neuromusculoskeletal therapy
Provide neuromusculoskeletal therapies
Provide neuromusculoskeletal therapy
Smallpox

Traduction de «therapies had been » (Anglais → Français) :

TERMINOLOGIE
voir aussi les traductions en contexte ci-dessous
Royal Commission on Complaints of Canadian Citizens of Japanese Origin who Resided in British Columbia in 1941, that their real and Personal Property had been Disposed of by the Custodian of Enemy Property at Prices Less than the Fair Market Value

Royal Commission on Complaints of Canadian Citizens of Japanese Origin who Resided in British Columbia in 1941, that their real and Personal Property had been Disposed of by the Custodian of Enemy Property at Prices Less than the Fair Market Value


forced maximal expiratory flow after 50% of the FVC had been exhaled | FEF50% | MMFR | maximal mid-expiratory flow rate

débit maximum expiratoire 50 p. cent | D.M.E. 50 p. cent


Smallpox[Footnote: In 1980 the 33rd World Health Assembly declared that smallpox had been eradicated. The classification is maintained for surveillance purposes.]

Variole


An extremely rare tumour association characterised by dual predisposition to melanoma and neural system tumours (typically astrocytoma). Fewer than 20 affected families have been reported to date. Affected individuals had cutaneous melanoma in associ

syndrome mélanome-tumeur du système nerveux


frozen meat of animals which had lived in the wild state and had been killed by hunting

viande congelée provenant d'animaux ayant vécu à l'état sauvage et ayant été abattus à la chasse


antiretroviral therapy | antiretroviral treatment | combination therapy | combined antiretroviral therapy | highly active antiretroviral therapy | ART [Abbr.]

multithérapie


offer neuromusculoskeletal therapy | provide neuromusculoskeletal therapies | offer neuromusculoskeletal therapies | provide neuromusculoskeletal therapy

délivrer un traitement neuro-musculo-squelettique


dietary therapy | nutrition therapy | nutritional therapy

thérapie nutritionnelle


A rare craniosynostosis syndrome with characteristics of scaphocephaly, macrocephaly, severe maxillary retrusion, and mild intellectual disability. It has been reported in 11 patients from a three-generation family. The patients had variable dysmorph

scaphocéphalie familiale type McGillivray


Definition: The patient has had two or more depressive episodes as described in F33.0-F33.3, in the past, but has been free from depressive symptoms for several months.

Définition: Le sujet a eu, dans le passé, au moins deux épisodes dépressifs répondant aux descriptions données en F33.0-F33.3, mais ne présente aucun symptôme dépressif depuis plusieurs mois.
TRADUCTIONS EN CONTEXTE
According to data reported by the Member States, approximately 60 derogations from the obligation to obtain a marketing authorisation prior to the marketing of advanced therapies had been granted until April 2012.[15] Derogations were granted under Article 3(7) of Directive 2001/83 (so-called "hospital exemption") as well as under other provisions of the Directive, notably Article 5.[16]

D’après les données fournies par les États membres, une soixantaine de dérogations à l’obligation d’obtenir une autorisation de mise sur le marché avant la commercialisation de produits de thérapies innovantes ont été accordées jusqu’en avril 2012[15], au titre de l’article 3, paragraphe 7 (dans le cadre de l’«exemption hospitalière»), et d’autres dispositions de la directive 2001/83/CE, notamment son article 5[16].


According to data reported by the Member States, approximately 60 derogations from the obligation to obtain a marketing authorisation prior to the marketing of advanced therapies had been granted until April 2012.[15] Derogations were granted under Article 3(7) of Directive 2001/83 (so-called "hospital exemption") as well as under other provisions of the Directive, notably Article 5.[16]

D’après les données fournies par les États membres, une soixantaine de dérogations à l’obligation d’obtenir une autorisation de mise sur le marché avant la commercialisation de produits de thérapies innovantes ont été accordées jusqu’en avril 2012[15], au titre de l’article 3, paragraphe 7 (dans le cadre de l’«exemption hospitalière»), et d’autres dispositions de la directive 2001/83/CE, notamment son article 5[16].


A Commission report of March 2014 examined the status of advanced therapies in the EU and how the regulation had worked in practice.

Un rapport de la Commission de mars 2014 a examiné la situation des thérapies innovantes dans l’UE ainsi que le fonctionnement du présent règlement dans la pratique.


A Commission report of March 2014 examined the status of advanced therapies in the EU and how the regulation had worked in practice.

Un rapport de la Commission de mars 2014 a examiné la situation des thérapies innovantes dans l’UE ainsi que le fonctionnement du présent règlement dans la pratique.


For more results, go to https://pro.wordscope.com to translate your documents with Wordscope Pro!
It noted that the legislation had established a recognised framework for assessing new advanced therapies.

Le rapport indique que la législation a établi un cadre reconnu d’évaluation des nouvelles thérapies innovantes.


A few countries (such as France, Germany, Italy, the Netherlands and Spain) also have, or have had, specific initiatives and incentives in place to boost RD in the field of orphan medicinal products and other innovative therapies at national level.

Plusieurs pays (dont l’Allemagne, l’Espagne, la France, l’Italie et les Pays-Bas) recourent aussi à des initiatives et à des mesures incitatives spécifiques pour stimuler la recherche-développement dans le domaine des médicaments orphelins et d’autres thérapies innovantes à l’échelle nationale.


These two reports can be likened to a scenario where a medical panel determines that the therapy used for a patient so far has caused him harm and made his condition worse, and then proceeds to say that the therapy prescribed on the basis of the diagnosis must be continued, that they must continue what they had done before, but with stricter supervision and punishing the patient if he does not comply, if, for instance, he fails to take his medication.

On peut comparer ces deux rapports à un scénario dans lequel un panel médical détermine que la thérapie suivie jusqu’ici par un patient lui a fait du tort et a aggravé son état, mais affirme également qu’il faut poursuivre la thérapie prescrite sur la base du diagnostic, qu’il faut continuer comme avant, mais avec une surveillance plus stricte et en punissant le patient s’il ne respecte pas les consignes, par exemple s’il ne prend pas ses médicaments.


A few countries (such as France, Germany, Italy, the Netherlands and Spain) also have, or have had, specific initiatives and incentives in place to boost RD in the field of orphan medicinal products and other innovative therapies at national level.

Plusieurs pays (dont l’Allemagne, l’Espagne, la France, l’Italie et les Pays-Bas) recourent aussi à des initiatives et à des mesures incitatives spécifiques pour stimuler la recherche-développement dans le domaine des médicaments orphelins et d’autres thérapies innovantes à l’échelle nationale.


A Commission report of March 2014 examined the status of advanced therapies in the EU and how the regulation had worked in practice.

Un rapport de la Commission de mars 2014 a examiné la situation des thérapies innovantes dans l’UE ainsi que le fonctionnement du présent règlement dans la pratique.


It noted that the legislation had established a recognised framework for assessing new advanced therapies.

Le rapport indique que la législation a établi un cadre reconnu d’évaluation des nouvelles thérapies innovantes.


w